Zohar Nevo

Associate - Boston

Zohar Nevo
Download Media Photo

Contact Information

617.832.1178

617.832.7000

znevo@foleyhoag.com Download vCard

Zohar Nevo is a business attorney with substantial international experience. He focuses on mergers and acquisitions and venture capital finance transactions. He advises buy-side and sell-side clients in domestic as well as cross-border transactions where he represents both domestic clients to make cross-border acquisitions and investments as well as foreign companies making acquisitions in the United States. Zohar represents strategic buyers in a broad mix of industries including the life sciences and technology.  He also represents emerging growth companies that are seeking financing and working towards an “exit.”

Zohar also counsels clients on their day-to-day legal needs. This includes providing corporate governance advice, attending Board and committee meetings, assisting companies with negotiating and drafting commercial agreements.

More »

Education:

  • University College London, LLM, 2016
  • The Hebrew University of Jerusalem, MBA, 2011
  • The Hebrew University of Jerusalem, LLB, 2010

Languages:

English, Hebrew, Arabic (intermediate)

Representative Experience

Representative M&A Transactions 

  • Thermo Fisher Scientific Inc. (NYSE: TMO) in its acquisition of programmable dye platform pioneer Phitonex, Inc. (2020) 
  • Kyruus in its acquisition of HealthSparq (2020)
  • Entegris (Nasdaq: ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, in its $36 million acquisition of Global Measurement Technologies (2020)
  • New-Indy Containerboard, a joint-venture formed by the Kraft Group and Schwarz Partners, LP, in its acquisition of Shoreline Container (2020)
  • Entegris (Nasdaq: ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, in its acquisition of Sinmat for $75 million (2020)
  • Rand-Whitney Container LLC in its acquisition of the assets of Specialty Finance & Consulting Corporation (2019)
  • Represented Entegris, Inc. in the acquisition of MPD Chemicals for approximately $165 million (2019)

Representative Financing Transactions 

  • LinearB in its $16M Series A Financing (2021)
  • TrialJectory in its Series A-1 Financing (2021) 
  • Ovia Health (formerly known as Ovuline) in its Series B Financing (2020)
  • Kebotix in its $11.5 million Series A Financing (2020)
  • Aquant in its $30 million Series B Financing (2020)
  • TrialJectory in its Series Seed Financing (2019)
  • Bessemer Venture Partners, as lead investor in the Series C financing of smart water dispenser Bevi (Hydration Labs) (2019)
  • Early stage venture capital firm .406 Ventures in its $9 million Series A investment in log search and analytics platform CHAOSSEARCH (2019)
 

Involvement

  • New York State Bar Association, Member
  • Israel Bar Association, Member
  • Boston Bar Association, Member
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts
  • New York
  • Israel